A phase II study of sorafenib in patients with chemo-naive castration-resistant prostate cancer.
Chi KN, Ellard SL, Hotte SJ, Czaykowski P, Moore M, Ruether JD, Schell AJ, Taylor S, Hansen C, Gauthier I, Walsh W, Seymour L.
Chi KN, et al. Among authors: ruether jd.
Ann Oncol. 2008 Apr;19(4):746-51. doi: 10.1093/annonc/mdm554. Epub 2007 Dec 3.
Ann Oncol. 2008.
PMID: 18056648
Free article.
Clinical Trial.